ArticleJournal of the American Geriatrics Society2021
Primary care clinician and community pharmacist perceptions of deprescribing.
Article in Journal of the American Geriatrics Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 22 citations in OpenAlex.
- Instruments for assessing healthcare professionals' knowledge, attitudes and practices regarding deprescribing: a scoping review.International journal of clinical pharmacy · 2026Review
- Evaluation of a Pharmacist-Led Intervention Focused on the Deprescribing of Cardiovascular and Antidiabetic Medication in Older Patients With Polypharmacy: Patients' and Pharmacists' Experiences.Basic & clinical pharmacology & toxicology · 2026Article
- What Deprescribing Information Should Be Communicated on Discharge and How? A Qualitative Study of Pharmacists' Perspectives on Deprescribing at Transitions of Care.Australasian journal on ageing · 2026Article
- Medication Use Patterns, Polypharmacy, and Potentially Inappropriate Medications among Institutionalized Older Adults in East Coast Malaysia: A Cross-sectional Study.Journal of research in pharmacy practice · 2026Article
- Polypharmacy as a Chronic Condition: A Diagnostic Mindset for Safer and Smarter Care.Journal of clinical medicine · 2025Article
- Reframing Polypharmacy: Empowering Medical Students to Manage Medication Burden as a Chronic Condition.Clinics and practice · 2025Article
- Author's Reply: Methodological Considerations to Enhance the Relevance of Causal Observational Research in the Field of Kidney Disease.Journal of the American Society of Nephrology : JASN · 2025Article
- Deprescribing NSAIDs: The Potential Role of Community Pharmacists.Pharmacy (Basel, Switzerland) · 2024Article
- Unlocking Deprescribing Potential in Nursing Homes: Insights from a Focus Group Study with Healthcare Professionals.Drugs & aging · 2024Article
- Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review.npj aging · 2024Review
- Attitudes and beliefs of older adults and caregivers towards deprescribing in French-speaking countries: a multicenter cross-sectional study.European journal of clinical pharmacology · 2022Article
- Implementation of pharmacist-led deprescribing in collaborative primary care settings.International journal of clinical pharmacy · 2022Article
- Patients' attitudes toward deprescribing and their experiences communicating with clinicians and pharmacists.Therapeutic advances in drug safety · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.